Evaluation of Hematological, Biochemical Profiles and Molecular Detection of Envelope Gene (gp-41) in Human Immunodeficiency Virus (HIV) among Newly Diagnosed Patients
Authors:
- Asfa AnjumAAAsfa Anjum
- Abaid Ur RehmanARAbaid Ur Rehman
- Hina SiddiqueHSHina Siddique
- Ali A. RabaanARAli A. Rabaan
- Saad AlhumaidSaad Alhumaid
- Mohammed GaroutMGMohammed Garout
- Souad A. AlmuthreeSASouad A. Almuthree
- Muhammad A. HalwaniMHMuhammad A. Halwani
- Safaa A. TurkistaniSTSafaa A. Turkistani
- Haitham QutobHQHaitham Qutob
- Hawra AlbayatHAHawra Albayat
- Mohammed AljeldahMAMohammed Aljeldah
Open Access
Abstract
The Human Immunodeficiency Virus (HIV) is a highly morphic, retrovirus that rapidly evolves through mutation as well as recombination. Because of the immunocompromised status in HIV patients, there is often a higher chance of acquiring different secondary infections followed by liver cirrhosis, hepatitis B & C, and HIV-associated nephropathy. The current study was conducted to see the prevalence of secondary infections, hematological and biochemical markers for liver and renal associated diseases, and to detect the envelope gene (GP41) in newly diagnosed HIV patients. A total of 37 samples were collected from HIV-positive patients registered in different hospital settings under the National AIDS control program. The collected samples were processed for hepatitis B, hepatitis C, hematological analysis, and biochemical analysis. To identify the envelope gene in newly diagnosed HIV patients, polymerase chain reaction (PCR) was performed using four gene-specific primers. The HIV infections were seen more in male as compared to females. A significant decrease in complete blood count was observed in HIV patients when compared to healthy individuals. There was a significant increase in aspartate aminotransferase (AST), alanine aminotransferase (ALT), urea, and creatinine observed in HIV patients. No significant difference was observed in alkaline phosphatase (ALP), total bilirubin, and albumin levels when compared to healthy control. Anemia was observed in 59.4% of HIV patients. A total of three (8.1%) patients were found to be co-infected with hepatitis B and one (2.7 %) was co-infected with hepatitis C. Out of these 37 tested samples, a total of four showed the successful amplification of the envelope gene. This study provides platform for the health care facilitators to regularly monitor the signs, symptoms and clinical biomarkers of HIV-associated infections to prevent toxicity at an early stage to improve the quality of life (QoL) and minimize the mortality rate in HIV patients. Envelope gene mutating frequently results in drug resistance, and thus future research on polymorphism analysis will reveal points of substitutions to improve drug designing.Keywords
This publication has 37 references indexed in Scilit:
- HIV stigma and disclosure experiences of people living with HIV in an urban and a rural settingAIDS Care, 2015
- Origin of the HIV-1 group O epidemic in western lowland gorillasProceedings of the National Academy of Sciences, 2015
- Modelling binding between CCR5 and CXCR4 receptors and their ligands suggests the surface electrostatic potential of the co-receptor to be a key player in the HIV-1 tropismRetrovirology, 2013
- HIVand co‐infectionsImmunological Reviews, 2013
- Current trends of HIV recombination worldwideInfectious Disease Reports, 2013
- HBV and HCV seroprevalence and their correlation with CD4 cells and liver enzymes among HIV positive individuals at University of Gondar Teaching Hospital, Northwest EthiopiaVirology Journal, 2013
- Compensatory mutations rescue the virus replicative capacity of VIRIP-resistant HIV-1Antiviral Research, 2011
- Prevalence of HIV, HCV and sexually transmitted infections among injecting drug users in Rawalpindi and Abbottabad, Pakistan: evidence for an emerging injection-related HIV epidemicSexually Transmitted Infections, 2009
- Haematological abnormalities associated with paediatric HIV/AIDS in LagosPaediatrics and International Child Health, 2006
- Alanine Scanning Mutants of the HIV gp41 LoopJournal of Biological Chemistry, 2005